In multiple hSOD-1 mutated Drosophila models of ALS, fisetin has lessened both mutant and wild hSOD-1 in vivo and in vitro and has shown significant neuroprotection by attenuating motor impairments, regulating redox homeostasis, and reducing ROS damage [128]. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.